Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Haematologica. 2021 Apr 1. doi: 10.3324/haematol.2020.274258. Online ahead of print.ABSTRACTB-cell non-Hodgkin's lymphoma (B-NHL) encompasses multiple clinically and phenotypically distinct subtypes of malignancy with unique molecular etiologies. Common subtypes of B-NHL such as diffuse large B-cell lymphoma (DLBCL) have been comprehensively interrogated at the genomic level. But rarer subtypes such as mantle cell lymphoma (MCL) remain sparsely characterized. Furthermore, multiple B-NHL subtypes have thus far not been comprehensively compared using the same methodology to identify conserved or subtype-specific patterns of genomic alterations. Here, we employed a large targeted hybrid-capture sequencing approach encompassing 380 genes to interrogate the genomic landscapes of 685 B-NHL tumors at high depth; including DLBCL, MCL, follicular lymphoma (FL), and Burkitt lymphoma (BL). We identified conserved hallmarks of B-NHL that were deregulated in the majority of tumor from each subtype, including the frequent genetic deregulation of the ubiquitin proteasome system (UPS). In addition, we identified subtype-specific patterns of genetic alterations, including clusters of co-occurring mutations and DNA copy number alterations. The cumulative burden of mutations within a single cluster were more discriminatory of B-NHL subtypes than individual mutations, implicating likely patterns of genetic cooperation that contribute to disease etiology. We therefore provide the first cross-sect...
Source: Haematologica - Category: Hematology Authors: Man Chun John Ma Saber Tadros Alyssa Bouska Tayla Heavican Haopeng Yang Qing Deng Dalia Moore Ariz Akhter Keenan Hartert Neeraj Jain Jordan Showell Sreejoyee Ghosh Lesley Street Marta Davidson Christopher Carey Joshua Tobin Deepak Perumal Julie M Vose Mat Source Type: research
More News: Burkitt Lymphoma | Cancer & Oncology | Genetics | Hematology | Hodgkin's Disease | Jordan Health | Lymphoma | Middle East Health | Non-Hodgkin's Lymphoma